ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Pharmaceuticals

Japan in talks to secure coronavirus vaccine from AstraZeneca

Daiichi Sankyo to distribute doses if UK development is successful

AstraZeneca aims to supply Japan with a vaccine in cooperation with its group companies, Daiichi Sankyo and Meiji Holdings.   © Reuters

TOKYO -- Japanese pharmaceutical company Daiichi Sankyo is in discussions to secure Japan supplies of a potential coronavirus vaccine being developed by British pharmaceutical giant AstraZeneca and Oxford University.

Daiichi Sankyo announced in a news release that a subsidiary in Saitama Prefecture would receive undiluted solution of the potential vaccine known as AZD1222 and then carry out formulation work, packaging and storage in Japan.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more